Compound 1469
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)N(C)Cc1ccccc1-c1ccc(Cl)cc1
- IUPAC name:
4-[4-[[2-(4-chlorophenyl)phenyl]methyl-methylamino]piperidin-1-yl]-N-[4-[[(2S)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide
- InChi:
InChI=1S/C44H49ClN6O5S2/c1-48(2)26-23-36(31-57-39-10-5-4-6-11-39)46-42-22-21-40(29-43(42)51(53)54)58(55,56)47-44(52)33-15-19-38(20-16-33)50-27-24-37(25-28-50)49(3)30-34-9-7-8-12-41(34)32-13-17-35(45)18-14-32/h4-22,29,36-37,46H,23-28,30-31H2,1-3H3,(H,47,52)/t36-/m1/s1
- InChiKey:
UDJXGLNJAAKABM-PSXMRANNSA-N
External links
![]() 71025282 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Haixiao Zhai, Xiong Cai, Curis, Inc.. . Bcl-2 inhibitors None. | 9 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 840.29 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 7.74 | |||
TPSA | 130.81 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009036035 | 9 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.30 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5475 | Navitoclax | DB12340 | |
0.4730 | Venetoclax | DB11581 | |
0.4148 | Sulfabenzamide | DB09355 | |
0.4070 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 | |
0.4037 | Quinethazone | DB01325 | |
0.4000 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.3990 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.3964 | Nelfinavir | DB00220 | |
0.3942 | Avagacestat | DB11893 | |
0.3941 | Clorexolone | DB13617 | |
0.3924 | Repinotan | DB06506 | |
0.3917 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.3913 | TAK-901 | DB12756 | |
0.3902 | [4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone | DB01836 | |
0.3881 | Anatibant | DB05038 |